Electronic Cigarettes and Vaping in Allergic and Asthmatic Disease

Electronic nicotine delivery systems (ENDS) were introduced in 2006, offering alternatives to combustible cigarettes. There is significant controversy regarding their sale and regulation, particularly with youth and high-risk patient populations. They were deemed a “major public health concern” by the United States (US) Surgeon General in 2016 . Already associated with health consequences, recently e-cig or vaping product use-associated lung injury (EVALI) has exposed their potential to cause life-threatening complications. This publication aims to educate readers on the the immediate and long-term health consequences of ENDS, so they may provide patient counseling on utilization focusing on the asthmatic population.
Source: Immunology and Allergy Clinics of North America - Category: Allergy & Immunology Authors: Source Type: research